33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15823)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7078)
  4. Hematologic Malignancies, Division of (6211)
  5. Center for Hematologic Malignancies (6018)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4873)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15823)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7078)
  4. Hematologic Malignancies, Division of (6211)
  5. Center for Hematologic Malignancies (6018)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic value of the lung immune prognostic index in patients with untreated advanced renal cell carcinoma (aRCC) receiving nivolumab plus ipilimumab (N+I) or sunitinib (SUN) in the CheckMate 214 trial
    Meeting Abstract

    Carril-Ajuria, L.; Motzer, R. J.; Tannir, N. M.; McDermott, D. F.; Hammers, H. J.; Plimack, E. R.; Donskov, F.; Rini, B. I.; Jiang, R.; Lee, C. W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions
    Meeting Abstract

    Carrizosa, D. R.; Burkard, M. E.; Elamin, Y. Y.; Desai, J.; Gadgeel, S. M.; Lin, J. J.; Waqar, S. N.; Spigel, D. R.; Chae, Y. K.; Cheema, P. K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Examination of speakership gender disparity at an international oncology conference
    Meeting Abstract

    Caro, J.; Boatwright, C.; Li, X.; Fiocco, C.; Stempel, J. M.; Stoeckle, J. H.; Smithy, J. W.; Warner, A. B.; Shum, E.; Sabari, J. K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Use and correlates of carotid ultrasound in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
    Meeting Abstract

    Bryce, Y. C.; Armstrong, G. T.; Leisenring, W. M.; Whitton, J.; Chow, E. J.; Weil, B. R.; Dieffenbach, B.; Howell, R. M.; Oeffinger, K. C.; Nathan, P. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Largest evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated non-small cell lung cancer (NSCLC) and colorectal cancer (CRC): Plasma biomarker analysis of CodeBreaK100
    Meeting Abstract

    Li, B. T.; Velcheti, V.; Price, T. J.; Hong, D. S.; Fakih, M.; Kim, D. W.; Falchook, G. S.; Delord, J. P.; Dy, G. K.; Ramalingam, S. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Electronic research consents for complex early-phase I-II clinical trials integrated with telemedicine visits compared with in-person encounters
    Meeting Abstract

    Buckley, M. T.; O'Shea, M.; Lipitz-Snyderman, A.; Kuperman, G.; Shah, S.; Redelman-Sidi, Y.; Lengfellner, J. M.; Terzulli, S. L.; Houston, C.; Sabbatini, P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • ROCC/GOG-3043: A randomized non-inferiority trial of robotic versus open radical hysterectomy for early-stage cervical cancer
    Meeting Abstract

    Bixel, K. L.; Leitao, M. M.; Chase, D. M.; Quick, A.; Lim, P. C.; Eskander, R. N.; Gotlieb, W. H.; LoCoco, S.; Martino, M. A.; McCormick, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • COVID-19 in patients with gynecologic cancer: A preliminary report from the COVID-19 and Cancer Consortium (CCC19)
    Meeting Abstract

    Beeghly-Fadiel, A.; Prescott, L. S.; Ruiz-Garcia, E.; Hwang, C.; Heilman, H.; McKay, R. R.; Saliby, R. M.; Lau, S.; Nagaraj, G.; Puc, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1 trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors
    Meeting Abstract

    Bedard, P. L.; Hernando-Calvo, A.; Carvajal, R. D.; Morris, V. K.; Paik, P. K.; Zandberg, D. P.; Kaczmar, J. M.; Niculescu, L.; Bohr, D.; Reiners, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save